Loading…
Tuesday, June 26 • 8:00am - 9:15am
#208: Effective Management of Internal Stakeholders and External Strategic Partners from Multiple Perspectives: Non-Profit, CRO, and Pharmaceutical Industry

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Application UAN: 0286-0000-18-561-L04-P; CME 1.25; IACET 1.25; PDU 1.25 PMI 2166-000222; RN 1.25

Drug development has become an increasingly complex process due to rising costs, increased regulations, and the need to collaborate with essential internal and external stakeholders. Companies are embracing strategies to mitigate the risks of these costly and time sensitive development programs. This has resulted in an increasing number of companies in-licensing products and outsourcing development activities. Therefore, effective stakeholder management is an essential component of any successful drug development project. This forum will include three panelists who are experts in managing the collaborations and strategies for the biotech/pharmaceutical drug development process. This includes stakeholders such as business partners, non-profit consortiums, academia, key opinion leaders, and patient advocacy groups. Panelists will share their experiences and through case studies demonstrate some of the challenges they face in their individual unique settings. These challenges include how each business segment (advocacy, CRO, and medical affairs), define key stakeholders and how they developed plans to manage expectations and achieve project goals within set timeline and budget parameters.

Learning Objectives

Define stakeholders and recognize different levels of stakeholders; Identify key stakeholders and stakeholders in various settings from different perspectives; Recognize the similarities and differences of stakeholders in different settings; Identify risks and mitigation strategies; Develop a stakeholder management plan.

Chair

Jing Li

Speaker

Stakeholder Management: From Non-Profit and Industry/Academic/Government Consortium
Debora Merrill, MBA

Stakeholder Management: From CRO Perspective
Steven Innaimo, MS

Stakeholder Management: From Sponsor Medical Affairs Perspective
Stephen Apple, MD



Speakers
SA

Stephen Apple

Senior Medical Director, Mitsubishi Tanabe Pharma America
Dr. Apple has over 20 years of experience both nationally and internationally in all major segments of health care delivery: as a provider, educator, managed care consultant, and as a medical director Dr. Apple is currently Senior Medical Director for Mitsubishi Tanabe Pharma America... Read More →
avatar for Steven Innaimo

Steven Innaimo

Head, Program Management Office, Covance
Steve Innaimo is the head of the Covance Program Management Office and possesses more than 25 years of drug development experience in the pharma, biotech and CRO settings. Steve began his career as molecular biologist developing novel targeted gene therapies. During his 22 years with... Read More →
avatar for Jing Li

Jing Li

Head of Program Management Office, Castle Creek Pharmaceuticals
Jing Li is the Head of Program Management Office at Castle Creek Pharmaceuticals, responsible for managing all R&D programs under development. Jing is a passionate leader with strong management skills. Jing has 20 years of direct project management experience in large pharma, mid-size... Read More →
DM

Debora Merrill

Vice President, COPD Biomarker Qualification Consortium, COPD Foundation
As VP, COPD Biomarker Qualification Consortium (CBQC) for the COPD Foundation, Debbie focuses on integrating pharma, academic and government partners to qualify novel biomarkers and clinical outcome assessment tools supporting development of novel COPD therapies. Prior to that, Debbie... Read More →


Tuesday June 26, 2018 8:00am - 9:15am
Room 153ABC Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA